167 related articles for article (PubMed ID: 4013997)
1. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
Fung HL
Am Heart J; 1985 Jul; 110(1 Pt 2):213-6. PubMed ID: 4013997
[TBL] [Abstract][Full Text] [Related]
2. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
3. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina.
Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Bechtold H; Meinertz T; Fung HL
Clin Pharmacol Ther; 1983 Jun; 33(6):747-56. PubMed ID: 6851405
[TBL] [Abstract][Full Text] [Related]
4. Hepatic extraction of isosorbide dinitrate in cardiac patients.
Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Kasper W; Meinertz T; Fung HL
Clin Pharmacol Ther; 1983 Dec; 34(6):724-31. PubMed ID: 6641086
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
6. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous isosorbide-dinitrate.
Platzer R; Reutemann G; Galeazzi RL
J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
Morrison RA; Fung HL
J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
[TBL] [Abstract][Full Text] [Related]
9. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
11. Response to changing plasma concentrations of isosorbide-bound NO2 during acute and sustained treatment with isosorbide dinitrate in patients with coronary artery disease.
Jørgensen LH; Thaulow E; Bredesen J; Refsum HE
Clin Cardiol; 2000 Jun; 23(6):427-32. PubMed ID: 10875033
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to isosorbide dinitrate: rate of development and reversal.
Parker JO; Fung HL; Ruggirello D; Stone JA
Circulation; 1983 Nov; 68(5):1074-80. PubMed ID: 6616789
[TBL] [Abstract][Full Text] [Related]
13. Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate.
Fung HL; Ruggirello D; Stone JA; Parker JO
Z Kardiol; 1983; 72 Suppl 3():5-10. PubMed ID: 6666234
[TBL] [Abstract][Full Text] [Related]
14. Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.
Reed DE; Akester JM; Prather JF; Tuckosh JR; McCurdy DH; Yeh C
J Pharmacol Exp Ther; 1977 Jul; 202(1):32-7. PubMed ID: 874817
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
16. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
Menke G; Schnellhammer R; Rietbrock N
Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of low-dose isosorbide dinitrate and metabolites after buccal or oral administration].
Keller-Stanislawski B; Marschner JP; Rietbrock N
Arzneimittelforschung; 1992 Jan; 42(1):17-20. PubMed ID: 1586374
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of organic nitrates.
Bogaert MG
Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacology of isosorbide dinitrate after transdermal application].
Wildfeuer A; Laufen H; Leitold M
Arzneimittelforschung; 1985; 35(8):1289-91. PubMed ID: 4074445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
